Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Why choose index funds over active funds? Because broad diversification, lower costs, and proven long-term results often beat active management.
26,956 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Prediction-market odds now place bitcoin's year-end odds reaching 10%. This article breaks down what that means for y...
CSX stock has surged, but a move to Bank of America’s $46 target hinges on margin expansion and a steadier freight ma...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Five insiders each owning at least 10% recently sold shares of V2X, Inc., totaling 2.55 million shares for about $173...
A sudden 47% rise in Structure Therapeutics stock has traders buzzing while a major fund exits a multi-million dollar...
Nvidia stock hits highs, renewing the debate over whether now is the moment to buy. This guide breaks down what's dri...
As AI-driven demand accelerates, the real trade sits with the equipment suppliers that power chip production. ASML, A...
Brent crude traded around $97.5 per barrel at 9 a.m. ET on May 28, 2026, keeping the focus on the current price 2026....
The AI boom is reshaping markets, and Nvidia sits at the center. This article lays out three concrete reasons why now...
Medicare's IRMAA surcharges can shrink Social Security for high earners. The little known IRMAA rule ties premiums to...
A Digi International VP sold a stake amid a fast-changing IoT landscape. This article breaks down what such insider m...